Type 2 diabetes: open trials in Hong Kong

15 open trials have a site in Hong Kong. Registry data; only the trial team decides who can take part.

NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Queen Elizabeth Hospital-Hong Kong-51727, Hong Kong · Queen Mary Hospital, Hong Kong · Prince of Wales Hospital-Hong Kong-20715, Hong Kong · Gleneagles Hospital Hong Kong, Hong Kong
Registry updated 2026-10-28
NCT07775404
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Hong Kong · Shatin, Hong Kong
Registry updated 2026-10-01
NCT07660445
Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM
Trial Treatment · Chinese University of Hong Kong
Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin
Registry updated 2026-09-16
NCT07376486
Duodenal pulsENDO as an Early Treatment for Type 2 DM
Trial Treatment · Chinese University of Hong Kong
Chinese University of Hong Kong, Shatin
Registry updated 2026-09-15
NCT07390422
Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease
Trial Treatment · Chinese University of Hong Kong
Chinese University of Hong Kong, Shatin
Registry updated 2026-09-15
NCT03549754
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Research · AstraZeneca
Wan Chai
Registry updated 2026-09-09
NCT07728591
Blood-based sEV Proteins for Early Detection of 2 Diabetes
Research · Hong Kong Baptist University
Hong Kong Baptist University Mr. & Mrs. Chan Hon Yin Chinese Medicine Specialty Clinic and Good Clinical Practice Centre, Kowloon Tong
Registry updated 2026-07-30
NCT07570667
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms
Research · The University of Hong Kong
School of Public Health, The University of Hong Kong, Hong Kong
Registry updated 2026-05-06
NCT07437157
The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register
Research · Chinese University of Hong Kong
Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital, Hong Kong
Registry updated 2026-02-27
NCT06978023
Novel Chinese Medicine Formula for Diabetes
Trial Treatment · Phase 2 · Chinese University of Hong Kong
Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital, Hong Kong
Registry updated 2025-05-18
NCT06727409
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease
Trial Treatment · Phase 4 · Chinese University of Hong Kong
3M, Diabetes and Endocrine Research Center, Hong Kong
Registry updated 2025-03-05
NCT03875625
Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention
Trial Treatment · Chinese University of Hong Kong
The Chinese University of Hong Kong, Prince of Wale Hospital, Hong Kong
Registry updated 2025-02-13
NCT05268237
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Trial Treatment · Phase 1/2 · Biolingus
Clinical Trials Unit, Chinese University of Hong Kong, Hong Kong
Registry updated 2025-02-06
NCT06310148
Evaluation of the Chronic Disease Co-Care Pilot Scheme
Trial Treatment · The University of Hong Kong
Jockey Club Building for Interdisciplinary Research 5 Sassoon Road, Pok Fu Lam, HONG KONG, Hong Kong
Registry updated 2024-03-22
NCT06273761
Evaluation of Medication Management Service
Trial Treatment · The University of Hong Kong
Aberdeen Kai-Fong Welfare Association A-Lively Community Pharmacy, Hong Kong · PHARM+ The Lok Sin Tong Community Pharmacy, Hong Kong · PHARM+ YWCA Community Pharmacy, Hong Kong · PHARM+ St. James' Settlement Community Pharmacy, Hong Kong · PHARM+ Pok Oi Hospital Community Pharmacy, Hong Kong · PHARM+ Haven of Hope Community Pharmacy, Hong Kong · Hong Kong Sheng Kung Hui Welfare Council Community Pharmacy, Hong Kong · Health In Action Community Pharmacy, Hong Kong
Registry updated 2024-02-23

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error